5-烯丙基-2-(戊氧基)苯甲醚 | 94291-83-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 5-烯丙基-2-(戊氧基)苯甲醚
• 英文名称: (2-methoxy-4-prop-2-enylphenoxy)pentane
• 英文别名: 4-allyl-2-methoxy-1-(pentyloxy)benzene；4-allyl-2-methoxy-1-pentyloxy-benzene；4-Allyl-2-methoxy-1-pentyloxy-benzol；O-Pentyl-eugenol；5-allyl-2-(pentyloxy)anisole；2-methoxy-1-pentoxy-4-prop-2-enylbenzene
• CAS: 94291-83-5
• 化学式: C₁₅H₂₂O₂
• 分子量: 234.338
• InChiKey: JEQOQDNQQSEKIA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  17
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2909309090

反应信息

• 作为产物：
  描述：

  1-(4-Bromopentoxy)-2-methoxy-4-prop-2-enylbenzene 在 [1,3-bis(2,6-di-iso-propylphenyl)imidazol-2-ylidene]copper(I) tert-butoxide 、 二苯基硅烷 、 2-tert-butylphenol potassium salt 作用下， 以 1,4-二氧六环 为溶剂， 反应 24.0h， 以63%的产率得到5-烯丙基-2-(戊氧基)苯甲醚
  参考文献：
  名称：

  NHC-铜氢化物作为化学选择性还原剂：炔烃，烷基三氟甲磺酸酯和烷基卤化物的催化还原

  摘要：

  介绍了NHC-铜催化的末端炔和内部炔的Z选择性半还原，以及NHC-铜催化的伯烷基三氟甲磺酸酯，伯和仲烷基碘和溴化物的还原。这些实施例中证明的高化学选择性说明了氢化铜络合物作为还原剂的温和性质，其在合成化学中的应用超出了它们在还原活化烯烃和羰基化合物方面的传统作用。

  DOI：

  10.1016/j.tet.2014.04.004

文献信息

• Eugenol derived immunomodulatory molecules against visceral leishmaniasis
  作者：Mamilla R. Charan Raja、Anand Babu Velappan、Davidraj Chellappan、Joy Debnath、Santanu Kar Mahapatra

  DOI：10.1016/j.ejmech.2017.08.030

  日期：2017.10

  (∼4 folds) in L. donovani infected peritoneal macrophages. Comp.35 had also increased the IL-12 (∼6 folds) and decreased the IL-10 (∼3 folds) mRNA expression and release in vitro. Results of in vivo studies revealed that comp.35 treatment at 25 mg/kg body weight efficiently cleared the hepatic and splenic parasite burden with enhanced Th1 response in L. donovani infected BALB/c mice. Hence, this study

  内脏利什曼病（VL）是由利什曼原虫donovani引起的危及生命的传染病。它导致宿主防御系统中的严重免疫抑制。当前抗血管紧张肽药物的更高的细胞毒性，严格的副作用和较低的治疗指数（TI）使得开发具有更好抗血管紧张性活性和高TI值的新分子成为必要。在这项研究中，我们合成了丁子香酚的36种衍生物，并筛选了它们对多诺尼乳杆菌（L. donovani）的前鞭毛体和鞭毛体形式的活性。在合成的衍生物中，化合物。35显示出更好的活性antileishmanial针对细胞外前鞭毛体（IC 50 - 20.13±0.91μM）和胞内无鞭毛体（EC 50-4.25±0.26μM）。TI值（82.24±3.77）与两性霉素B和Miltefosine相比分别提高了10-13倍。与补偿治疗。35（5微克/毫升）增强了一氧化氮（NO）的产生，iNOS2 mRNA表达（〜8倍增加），并在减少的精氨酸酶-1活性（约为4倍）杜氏利什曼原虫感染的腹膜巨噬细胞。比较
• COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS
  申请人：The Procter & Gamble Company

  公开号：EP2595642A2

  公开（公告）日：2013-05-29
• Compositions Comprising Derivatives Of Essential Oil Compounds And Use In Personal Care Products
  申请人：Scott Douglas Craig

  公开号：US20120014883A1

  公开（公告）日：2012-01-19

  Compositions containing one or more derivatives of essential oil compounds for use in personal care compositions, such as compositions for oral, throat and skin care are disclosed. These derivatives include acetals of parent essential oil aldehydes and ketones; esters or ethers of parent essential oil alcohols and phenolics; and esters of parent essential oil acids. Examples of parent essential oil aldehydes and ketones include citral, cinnamic aldehyde, ρ-anisaldehyde, vanillin, ethyl vanillin, heliotropin, carvone, and menthone. Examples of parent essential oil alcohols and phenolics include thymol, eugenol, isoeugenol, dihydroeugenol, carvacrol, carveol, geraniol, nerol, vanillyl alcohol, heliotropyl alcohol, ρ-anisyl alcohol, cinnamyl alcohol and β-ionol. Examples of parent essential oil acids include ρ-anisic acid, cinnamic acid, vanillic acid and geranic acid. The present compositions comprising essential oil derivatives are useful as base flavor or base perfume for incorporation into personal care products and to provide other benefits including antimicrobial efficacy. Optionally the compositions will contain additional antimicrobially- or anti-inflammatory-effective components including those also derived from plant essential oils or synthetic versions thereof.
• [EN] COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS<br/>[FR] COMPOSITIONS COMPRENANT DES DÉRIVÉS DE COMPOSÉS D'HUILES ESSENTIELLES ET LEUR UTILISATION DANS LES PRODUITS D'HYGIÈNE CORPORELLE
  申请人：PROCTER & GAMBLE

  公开号：WO2012012385A2

  公开（公告）日：2012-01-26

  Compositions containing one or more derivatives of essential oil compounds for use in personal care compositions, such as compositions for oral, throat and skin care are disclosed. These derivatives include acetals of parent essential oil aldehydes and ketones; esters or ethers of parent essential oil alcohols and phenolics; and esters of parent essential oil acids. Examples of parent essential oil aldehydes and ketones include citral, cinnamic aldehyde, ρ-anisaldehyde, vanillin, ethyl vanillin, heliotropin, carvone, and menthone. Examples of parent essential oil alcohols and phenolics include thymol, eugenol, isoeugenol, dihydroeugenol, carvacrol, carveol, geraniol, nerol, vanillyl alcohol, heliotropyl alcohol, ρ-anisyl alcohol, cinnamyl alcohol and β-ionol. Examples of parent essential oil acids include ρ-anisic acid, cinnamic acid, vanillic acid and geranic acid. The present compositions comprising essential oil derivatives are useful as base flavor or base perfume for incorporation into personal care products and to provide other benefits including antimicrobial efficacy. Optionally the compositions will contain additional antimicrobially- or anti-inflammatory-effective components including those also derived from plant essential oils or synthetic versions thereof.
• [EN] COMPOSITIONS OF EUGENOL DERIVATIVES FOR TREATMENT OF VISCERAL LEISHMANIASIS<br/>[FR] COMPOSITIONS DE DÉRIVÉS D'EUGÉNOL POUR LE TRAITEMENT DE LA LEISHMANIOSE VISCÉRALE
  申请人：FOUNDATION FOR NEGLECTED DISEASE RES

  公开号：WO2019030643A1

  公开（公告）日：2019-02-14

  The present invention provides cyclic and acyclic derivatives of eugenol that exhibit antileishmanial activity against promastigote and amastigote forms of L. donovani.